Advanced Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.2 | Q2 | 56.5% | 0.651 | Q2 | 70.4% |
| 2024 | 2.6 | Q3 | 50.1% | 0.865 | Q1 | 80.3% |
| 2023 | 3.7 | Q2 | 75.7% | 1.063 | Q1 | 87.1% |
| 2022 | 4.6 | Q2 | 79.4% | 1.039 | Q1 | 87.1% |
| 2021 | 5.0 | Q2 | 78.0% | 1.134 | Q1 | 89.0% |
| 2020 | — | — | 0.125 | Q4 | 13.3% | |
| 2019 | — | — | — | 0.2% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2366-3987
region
Western Europe
coverage
2018-2026